FromAstraZeneca ([email protected])
Sent withMailchimp
Subject (77)Datroway granted Priority Review in the US as 1st-line treatment for patients
Preheader (150)Datroway granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for
Typography
Arial
Colors
Text Analysis
Body Words146
Subject Words12
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px778 px
X-Spam Score-0.1
Preheader OptimizedNo
Timing
Day of WeekFriday
TimeAfternoon

Datroway granted Priority Review in the US as 1st-line treatment for patients

Datroway granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for
Datroway granted Priority Review in the US as 1st-line treatment for patients